
CTOR Stock Price Prediction
Citius Oncology Inc
- Overview
- Forecast
- Valuation
Should I Buy Citius Oncology Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CTOR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
CTOR stock price ended at $0.67 on Wednesday, after rising 1.52%
The Citius Oncology Inc stock price increased by 1.52% on the last trading day (Wednesday Apr 2025), rising from 0.651 to 0.67. Throughout the last trading session, the stock experienced a fluctuation of 6.22% , ranging from a day low of $0.64 to a day high of 0.6798. The price has declined in 5 of the last 10 days, resulting in a total change of -2.05% during this period. On the last day, trading volume increase by -18.68K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 25.75K shares were traded, amounting to approximately 16.84K.
CTOR Technical Signals
CTOR(Citius Oncology Inc Corp) has 0 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-04-04. The total price change during this trend is -2.91%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of CTOR over the last 5 trading days is 27.88K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
CTOR Moving Average Analysis
Citius Oncology Inc's overall moving average trend leans more bearish as of Thursday, April 24, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $0.75, and $0.8. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.58, and $0.53. A break-down below any of these levels will issue sell signals.
CTOR Short Selling Analysis
The short sale ratio of Citius Oncology Inc(CTOR) as of 22 Apr 2025 is 3.51%, dropping from last trading day. With decreasing price from 0.62 to 0.66. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary

Strong sell
Sell
4
Buy
0
Moving Average
Swing

Stock Price Above SMA_5
Short Term

SMA_5 Below SMA_20
Mid Term

SMA_20 Below SMA_60
Long Term

SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish

No Data
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.07
Bearish
Momentum (10 days)
MOM_10 < 0
-0.01
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.05
Bearish
Moving Average
5-day SMA crosses below 10-day SMA
--
Bearish
CTOR Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Citius Oncology Inc(CTOR), our algorithm predicts CTOR's 1-month price at $0.72, with an 7.73%upwardshift. Using a similarity score up to 94.83%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Citius Oncology Inc (CTOR.O) stock, as of Sunday, April 13, 2025 , forecasts a 7.73% change over the next month, based on its high correlation with MLR.N stock patterns. The similarity between their price movements over the analyzed periods is 94.83%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

CTOR
Future prediction
Up: 7.73%

MLR
Up: 7.73%Similarity: 94.83%
Name
Similarity
Up/Down

MLR.N
94.83%
+7.73%

ECOR.O
94.79%
+6.62%

UEC.A
94.46%
+8.68%

FDX.N
94.25%
-2.37%

HPH.O
94.23%
-58.85%

ATHE.O
94.22%
-16.42%

COCP.O
94.19%
-1.67%

STEM.N
93.95%
-35.14%

SQNS.N
93.84%
-14.59%

FCNCA.O
93.67%
+12.61%
CTOR Seasonality Analysis
Based on CTOR's historical stock price data across all years, the probability of a positive return in April is66.67%, suggesting it maybe an ideal month to invest in CTOR. In contrast,Januaryoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Citius Oncology Inc (CTOR.O) stock in January has the highest probability of a positive return (100.00%), while June has the lowest probability (50.00%).
Performance Seasonality
The chart shows Citius Oncology Inc. (CTOR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

EU
enCore Energy Corp
1.420
USD
+9.23%

MNTK
Montauk Renewables Inc
2.240
USD
+1.82%

CAPR
Capricor Therapeutics Inc
13.150
USD
-5.33%

LPRO
Open Lending Corp
1.040
USD
+2.97%

MCS
Marcus Corp
16.310
USD
+0.18%

VEL
Velocity Financial Inc
17.620
USD
+0.28%

AUNA
Auna SA
6.910
USD
-0.86%

SMLR
Semler Scientific Inc
34.280
USD
+3.00%

CSV
Carriage Services Inc
39.770
USD
+0.45%

GNK
Genco Shipping & Trading Ltd
12.700
USD
+3.59%
FAQ

Should I buy Citius Oncology Inc (CTOR.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CTOR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

Which months have the highest win rate for buying Citius Oncology Inc (CTOR.O) stock in a year?

How has Citius Oncology Inc. (CTOR)'s stock price performed over the past three years?

Which bull technical signals does CTOR have?

Which bearish technical signals does CTOR have?

Is CTOR a buy based on overall technical signals summary?

What is the trend of Citius Oncology Inc (CTOR)'s moving average?

What is price prediction for CTOR stock next month?

